Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Night Eating Syndrome: A Psychiatric Disease, a Sleep Disorder, a Delayed Circadian Eating Rhythm, And/Or a Metabolic Condition? Publisher Pubmed



Shoar S1, 2 ; Naderan M2 ; Mahmoodzadeh H3 ; Shoar N4 ; Lotfi D1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Clinical Research Scientist, ScientificWriting Corporation, Houston, TX, United States
  2. 2. Faculty of Medicine, Tehran University of Medical Science, Tehran, Iran
  3. 3. Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran
  4. 4. Faculty of Medicine, Kashan University of Medical Science, Kashan, Iran

Source: Expert Review of Endocrinology and Metabolism Published:2019


Abstract

Introduction: Night Eating Syndrome (NES) refers to an abnormal eating behavior which presents as evening hyperphagia consuming >25% calorie intake and/or nocturnal awaking with food ingestion which occurs ≥2 times per week. Although the syndrome has been described more than seven decades ago, the literature has been growing slowly on its etiology, diagnosis, and treatment. Areas covered: The proposed treatment options for NES are all at a case-study level. Moreover, our understanding of its etiology, comorbidities, and diagnosis is still premature. We performed a literature review in Medline/PubMed to identify all the studies proposing a management plan for NES and summarized all the existing data on its diagnosis and treatment. Expert opinion: To date, none of the proposed treatment options for NES have been promising and long-term data on its efficacy is lacking. The slow growth of evidence on this debilitating but underreported condition may be due to unawareness among clinicians, under-reporting by patients, and unrecognized diagnostic criteria. Objective screening of symptoms during office visits especially for patients at a high-risk for NES will identify more patients suffering from the syndrome. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.